ArticleInternational journal of molecular sciences2025
Involvement of Orotic Acid in Mitochondrial Activity of Ovarian Granulosa Cells and Oocyte Meiotic Maturation.
Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Orotic acid (OA) is a natural component of milk and is found in many biological fluids such as human ovarian follicular fluid. However, its effect on ovarian cells is unknown. Some studies suggest that OA may alter lipid metabolism and energy production in cells. In the present study, we determine the effect of OA on mitochondrial function and lipid droplet content in the human granulosa cell line. The effect of OA on in vitro mouse oocyte maturation and mitochondrial activity was also investigated. We found that repeated exposure to OA (0.01-1000 µM) did not alter the viability of human epithelial (HOSEpiC) and granulosa (HGrC1) ovarian cells. HGrC1 cells treated with a high dose of OA (500 µM) showed a more aerobic and energetic phenotype than control cells, whereas this effect was not observed after treatment with lower doses (0.01 and 100 µM) of OA. In addition, OA at a high dose (500 µM) reduced lipid droplet (LD) content without altering glucose (GLUT1, GLUT4) and fatty acid transporter (SLC27A1) gene expression in HGrC1 cells. At the same time, OA at 100 µM did not disrupt mouse in vitro oocyte maturation, whereas OA at 500 µM inhibited this process by arresting oocytes at the germinal vesicle (GV) stage with a reduction in mitochondrial activity. Our results show that OA at high doses can disrupt female reproduction, but normal dietary orotate intake does not have a negative effect on ovarian function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.